Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

表观遗传学 生物 染色质 癌症 抗药性 遗传学 组蛋白 突变 基因 癌症研究 生物信息学
作者
Sihong Chen,Yingxi Zhao,Shougeng Liu,Jiayu Zhang,Yehuda G. Assaraf,Wei Cui,Lihui Wang
出处
期刊:Drug Resistance Updates [Elsevier BV]
卷期号:61: 100821-100821 被引量:33
标识
DOI:10.1016/j.drup.2022.100821
摘要

Despite the rapid advancement in the introduction of new drugs for cancer therapy, the frequent emergence of drug resistance leads to disease progression or tumor recurrence resulting in dismal prognosis. Given that genetic mutations are thought to be important drivers of anti-cancer drug resistance, it is of paramount importance to pin-point mutant genes that mediate drug resistance and elucidate the underlying molecular mechanisms in order to develop novel modalities to surmount chemoresistance and achieve more efficacious and durable cancer therapies. Cumulative evidence suggests that epigenetic alterations, especially those mediated by epigenetic enzymes with high mutation rates in cancer patients, can be a crucial factor in the development of chemoresistance. Mutant epigenetic enzymes have altered enzymatic activity which may directly or indirectly affect the level of histone modifications. This can change chromatin structure and function hence altering the expression of target genes and eventually lead to chemoresistance. In the current review, we summarize epigenetic enzyme mutations and the consequent mechanisms of drug resistance in pre-clinical drug-resistance models and relapsed cancer patient specimens. We also introduce previously unreported mutation sites in the DOT1 domain of DOT1L, which are related to lung cancer drug resistance. It is worth noting that mutations occur not only in domains with enzymatic activity but also in non-catalytic regions. Each protein domain is an evolutionarily conserved region with independent functional properties. This may provide a rationale for the potential development of small molecule inhibitors which target various functional domains of epigenetic enzymes. Finally, based on the multitude of mechanisms of drug resistance, we propose several therapeutic strategies to reverse or overcome drug-resistance phenotypes, with the aim to provide cancer patients with novel efficacious combination therapeutic regimens and strategies to improve patient prognosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坦率白萱应助精明怜南采纳,获得10
刚刚
冷艳语芙发布了新的文献求助10
2秒前
刘燕山发布了新的文献求助10
3秒前
薄荷惠发布了新的文献求助10
6秒前
姜彦乔完成签到 ,获得积分10
8秒前
12秒前
oooo发布了新的文献求助10
12秒前
fixit发布了新的文献求助10
14秒前
15秒前
ZJY发布了新的文献求助10
17秒前
17秒前
笔至梦花完成签到 ,获得积分10
18秒前
量子星尘发布了新的文献求助10
19秒前
科研通AI2S应助nini采纳,获得20
20秒前
Skuld发布了新的文献求助10
20秒前
22秒前
lhy完成签到,获得积分10
22秒前
23秒前
24秒前
深情安青应助科研通管家采纳,获得10
24秒前
Lucas应助科研通管家采纳,获得10
24秒前
研友_VZG7GZ应助科研通管家采纳,获得10
24秒前
桐桐应助科研通管家采纳,获得10
25秒前
科研通AI5应助科研通管家采纳,获得10
25秒前
充电宝应助科研通管家采纳,获得10
25秒前
MchemG应助科研通管家采纳,获得10
25秒前
Liufgui应助科研通管家采纳,获得20
25秒前
MchemG应助科研通管家采纳,获得10
25秒前
义气如萱完成签到 ,获得积分10
25秒前
星辰应助科研通管家采纳,获得10
25秒前
CodeCraft应助科研通管家采纳,获得10
25秒前
今后应助科研通管家采纳,获得10
25秒前
爆米花应助科研通管家采纳,获得10
25秒前
25秒前
czh应助科研通管家采纳,获得10
25秒前
25秒前
MchemG应助科研通管家采纳,获得10
25秒前
Liufgui应助Araa采纳,获得10
27秒前
张建发布了新的文献求助10
28秒前
huang发布了新的文献求助10
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988975
求助须知:如何正确求助?哪些是违规求助? 3531316
关于积分的说明 11253424
捐赠科研通 3269917
什么是DOI,文献DOI怎么找? 1804830
邀请新用户注册赠送积分活动 882063
科研通“疑难数据库(出版商)”最低求助积分说明 809068